SCHEMBL15908528

SCHEMBL15908528

CC(C)=NNC(=S)NCc1cc(F)ccc1Br

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.40
KDM4E B2RXH2 1/20 0.40
TDP1 Q9NUW8 5/20 0.40
MAPT P10636 5/20 0.40
LMNA P02545 4/20 0.40
ALDH1A1 P00352 3/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
HTT P42858 1/20 0.40
ATM Q13315 1/20 0.40
NPSR1 Q6W5P4 1/20 0.38
ALOX12 P18054 2/20 0.38
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
PLA2G1B P04054 1/20 0.37
ATG4B Q9Y4P1 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
GAA P10253 2/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2018990 0.84 KMT2A (0.39) L3MBTL1KDM4ETDP1MAPTLMNA
SCHEMBL2018991 0.84 KMT2A (0.39) L3MBTL1KDM4ETDP1MAPTLMNA
SCHEMBL12488189 0.84 MAPT (0.45) L3MBTL1TDP1MAPTLMNAALDH1A1
SCHEMBL16141883 0.83 ALDH1A1 (0.41) L3MBTL1KDM4ETDP1MAPTLMNA
SCHEMBL12491645 0.83 KMT2A (0.38) L3MBTL1KDM4EMAPTLMNAALDH1A1
SCHEMBL29372134 0.79 GAA (0.45) MAPTLMNAALDH1A1KMT2AALOX12
SCHEMBL2025930 0.79 GAA (0.45) MAPTLMNAALDH1A1KMT2AALOX12
SCHEMBL7797904 0.76 PLA2G1B (0.44) MAPTLMNAALDH1A1KMT2AMEN1
SCHEMBL13537180 0.75 MTNR1A (0.43) KMT2ANPSR1HDAC1HDAC6
SCHEMBL20472487 0.70 P2RX7 (0.43) ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9340523-B2 Certain dipeptidyl peptidase inhibitors FOCHON PHARMA, INC. (US) 2016-05-17 US disclosed
US-20140213590-A1 CERTAIN DIPEPTIDYL PEPTIDASE INHIBITORS FOCHON PHARMA, INC. (US) 2014-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140213590-A1 CERTAIN DIPEPTIDYL PEPTIDASE INHIBITORS DPP4, DPP3, DPP8 L3MBTL1 3471/4885KDM4E 3742/4885TDP1 2675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.